日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Early Symptom Response in Patients With Uncomplicated Urinary Tract Infection Treated With Gepotidacin or Nitrofurantoin: Pooled Analysis From Two Pivotal Phase 3 Studies

使用吉泊他辛或呋喃妥因治疗单纯性尿路感染患者的早期症状反应:两项关键性3期研究的汇总分析

Sheets, Amanda J; Dennison, Jeremy; Pogue, Jason M; Kaye, Keith S; Perry, Caroline; Millns, Helen; Díaz-Regañón, Jazmín; Janmohamed, Salim

Design, Synthesis, and Characterization of Novel, Subtype-Selective Fluorescent Antagonists Targeting the Nociceptin/Orphanin FQ Opioid Peptide Receptor

新型亚型选择性荧光拮抗剂的设计、合成和表征,该拮抗剂靶向伤害感受素/孤啡肽FQ阿片肽受体

Farmer, George J; Sanchez, Julie; Millns, Annabell; Antony, Tamzin; Canals, Meritxell; Lane, J Robert; Mistry, Shailesh N

Monocyte eukaryotic initiation factor 2 signaling differentiates 17-hydroxy-docosahexaenoic acid levels and pain

单核细胞真核起始因子2信号传导区分17-羟基二十二碳六烯酸水平和疼痛

Peter R W Gowler ,Asta Arendt-Tranholm ,James Turnbull ,Rakesh R Jha ,David Onion ,Tony Kelly ,Afroditi Kouraki ,Paul Millns ,Sameer Gohir ,Susan Franks ,David A Barrett ,Ana M Valdes ,Victoria Chapman

Efficacy and in vitro activity of gepotidacin against bacterial uropathogens, including drug-resistant phenotypes, in females with uncomplicated urinary tract infections: results from two global, pivotal, phase 3 trials (EAGLE-2 and EAGLE-3)

吉泊他辛对包括耐药表型在内的细菌性泌尿道病原体的疗效和体外活性,用于治疗女性非复杂性尿路感染:两项全球关键性 3 期试验(EAGLE-2 和 EAGLE-3)的结果

Scangarella-Oman, Nicole E; Butler, Deborah L; Breton, John; Brown, Derrek; Kasapidis, Cara; Millns, Helen; Huang, Chun; Perry, Caroline R; Sheets, Amanda J; Dennison, Jeremy; Janmohamed, Salim

Author Correction: Propylene glycol inactivates respiratory viruses and prevents airborne transmission

作者更正:丙二醇可灭活呼吸道病毒并阻止空气传播

Styles, Christine T; Zhou, Jie; Flight, Katie E; Brown, Jonathan C; Lewis, Charlotte; Wang, Xinyu; Oever, Michael Vanden; Peacock, Thomas P; Wang, Ziyin; Millns, Rosie; O'Neill, John S; Borodavka, Alexander; Grove, Joe; Barclay, Wendy S; Tregoning, John S; Edgar, Rachel S

Location and access to health courses for rural students: an Australian audit

澳大利亚农村学生健康课程的地点和获取途径:一项审计

McKinstry, Carol; Quilliam, Claire; Crawford, Nicole; Thompson, Jason; Sizer, Stephanie Millns

Propylene glycol inactivates respiratory viruses and prevents airborne transmission

丙二醇可灭活呼吸道病毒并防止空气传播

Christine T Styles, Jie Zhou, Katie E Flight, Jonathan C Brown, Charlotte Lewis, Xinyu Wang, Michael Vanden Oever, Thomas P Peacock, Ziyin Wang, Rosie Millns, John S O'Neill, Alexander Borodavka, Joe Grove, Wendy S Barclay, John S Tregoning, Rachel S Edgar

Selective androgen receptor modulation for muscle weakness in chronic obstructive pulmonary disease: a randomised control trial

选择性雄激素受体调节治疗慢性阻塞性肺疾病肌无力:一项随机对照试验

Mohan, Divya; Rossiter, Harry; Watz, Henrik; Fogarty, Charles; Evans, Rachael A; Man, William; Tabberer, Maggie; Beerahee, Misba; Kumar, Subramanya; Millns, Helen; Thomas, Sebin; Tal-Singer, Ruth; Russell, Alan J; Holland, Marie Claire; Akinseye, Chika; Neil, David; Polkey, Michael I

Efficacy and Safety of Gepotidacin as Treatment of Uncomplicated Urogenital Gonorrhea (EAGLE-1): Design of a Randomized, Comparator-Controlled, Phase 3 Study

吉泊他辛治疗单纯性泌尿生殖道淋病的疗效和安全性(EAGLE-1):一项随机、对照、3期研究的设计

Perry, Caroline R; Scangarella-Oman, Nicole E; Millns, Helen; Flight, William; Gatsi, Sally; Jakielaszek, Charles; Janmohamed, Salim; Lewis, David A

2837. Impact of Regulatory Guidelines on Therapeutic, Clinical, and Microbiological Success Rates in Uncomplicated Urinary Tract Infection: Results from a Two Phase 3 Randomized Controlled Trials of Oral Gepotidacin (EAGLE-2 and EAGLE-3)

2837. 监管指南对非复杂性尿路感染的治疗、临床和微生物学成功率的影响:两项口服吉泊他辛 3 期随机对照试验(EAGLE-2 和 EAGLE-3)的结果

Botsford, Sabrina L; Yang, Sharon; George, Tony P; Wagenlehner, Florian; Perry, Caroline R; Hooton, Thomas M; Scangarella-Oman, Nicole E; Millns, Helen; Jarvis, Emily; Dennison, Jeremy; Sheets, Amanda; Janmohamed, Salim